Stock Events

Stock Events

Celldex Therapeutics (TCE2.STU) Q3 2026 Earnings

6AugConfirmed

Q1 2026

Q2 2026

Next

-1.03

-0.98

-0.92

-0.87

Details

Expected EPS

-0.9060450085199999

Actual EPS

N/A

Surprise EPS

0.91

Surprise Percent

+100%

Description

Celldex Therapeutics (TCE2.STU) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.